| Tong, Yeqing |
NCT04911790: Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults |
|
|
| Completed | 4 | 131650 | RoW | Experimental Group, CoronaVac | Sinovac Research and Development Co., Ltd. | COVID-19 | 01/23 | 08/23 | | |
NCT04992208: Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents |
|
|
| Completed | 4 | 31041 | RoW | Experimental Group, CoronaVac | Sinovac Life Sciences Co., Ltd. | COVID-19 | 03/23 | 08/23 | | |
NCT05216484: Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses) |
|
|
| Recruiting | 3 | 480 | RoW | SARS-CoV-2 Vaccine, Inactivated (Vero Cell) | Chinese Academy of Medical Sciences, Hubei Provincial Center for Disease Control and Prevention | SARS-CoV-2 Infection | 10/22 | 12/22 | | |
| Tang, Shengchun |
NCT05216484: Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses) |
|
|
| Recruiting | 3 | 480 | RoW | SARS-CoV-2 Vaccine, Inactivated (Vero Cell) | Chinese Academy of Medical Sciences, Hubei Provincial Center for Disease Control and Prevention | SARS-CoV-2 Infection | 10/22 | 12/22 | | |
